Gastroenteropancreatic neuroendocrine tumours - Modlin, Irvin M; Oberg, Kjell; Chung, Daniel C; Jensen, Robert T; de Herder, Wouter W; Thakker, Rajesh V; Caplin, Martyn; Delle Fave, Gianfranco; Kaltsas, Greg A; Krenning, Eric P; Moss, Steven F; Nilsson, Ola; et al. (The lancet oncology, 2008)
Keywords: Animals; Biology; Biomarkers, Tumor; Black people; Cancer therapies; Carcinoma, Neuroendocrine - classification; Carcinoma, Neuroendocrine - metabolism; Carcinoma, Neuroendocrine - pathology; Disease; Epidemiology; Ethnicity; Gastrointestinal Neoplasms - metabolism; Gastrointestinal Neoplasms - physiopathology; Gastrointestinal Neoplasms - therapy; Hematology, Oncology and Palliative Medicine; Humans; Kinases; MEDICIN; MEDICINE; Molecular Biology; Neuroendocrine tumors; Pancreatic Neoplasms - metabolism; Pancreatic Neoplasms - physiopathology; Pancreatic Neoplasms - therapy; Patients; Peptides; Protein-Tyrosine Kinases - antagonists & inhibitors; Small intestine; Somatostatin - analogs & derivatives; Somatostatin - metabolism; Somatostatin - therapeutic use; White people; United States--US